Sofina led the round with participation from OMERS Ventures and Index Ventures to accelerate growth in the UK and Europe.
"With millions of clinical data points collected each month, we plan on deriving personalised and predictive insights to enable a value-based healthcare delivery model. This latest investment, just over one year from the last round, is not only a validation of Birdie’s growth trajectory, but also an endorsement for the potential of our social impact."